Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER 78 INDUSTRY 32 NIH 3 OTHER_GOV 2 UNKNOWN 1 NETWORK 1 INDIV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 2 Head & Neck 1 Genitourinary 1 Gastrointestinal 1 Breast 1

Conditions

Prostatic Neoplasms 134 Urinary Bladder Neoplasms 47 Kidney Neoplasms 38 Carcinoma, Renal Cell 30 Wilms Tumor 29 Testicular Neoplasms 21 Urethral Neoplasms 16 Ovarian Neoplasms 15 Neoplasm Metastasis 14 Breast Neoplasms 14 Neuroblastoma 12 Sarcoma 11 Teratoma 10 Carcinoma, Non-Small-Cell Lung 9 Testicular Germ Cell Tumor 8 Precursor Cell Lymphoblastic Leukemia-Lymphoma 8 Ovarian Germ Cell Cancer 8 Lung Neoplasms 8 Endodermal Sinus Tumor 8 Colorectal Neoplasms 7 Burkitt Lymphoma 7 Seminoma 6 Osteosarcoma 6 Neoplasms 6 Colonic Neoplasms 6 Carcinoma, Ovarian Epithelial 6 Teratoma, Testicular 5 Recurrence 5 Pain 5 Head and Neck Neoplasms 5

Interventions

enzalutamide 1 darolutamide 1 apalutamide 1 abiraterone 1 Docetaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Adenocarcinoma × Genitourinary × Clear all

NCT06592924 2026-04-14

TRIPLE-SWITCH

Canadian Cancer Trials Group

Phase 3 Recruiting

Adenocarcinoma, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡